# MANÜ Telehealth reviews (2026): GLP-1 telehealth sellers | This GLP

Two plans per molecule, split by dose rather than by term, with both figures published.

Publisher: This GLP Editorial Team
Canonical: https://thisglp.com/reviews/manu-telehealth
Updated: 2026-10-28

By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Starter and full dose, priced

# MANÜ Telehealth review

Two plans per molecule, split by dose rather than by term, with both figures published.

## The verdict

MANÜ Telehealth publishes a Semaglutide Starter Plan from $199 and a Full Dose Plan at $299, with tirzepatide at $297 and $397. The split is by dose rather than by commitment length.

**Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures).

Category

GLP-1 telehealth

Molecule

Semaglutide · Tirzepatide

Form

Injection

From

From $199/mo

Prescription

Required

Compounded

Yes — not FDA-approved

MANÜ Telehealth sells both molecules by injection across two plans each. The Starter Plan is described as entry pricing for patients starting or staying on lower doses.

1.  ## Who writes the prescription, and what do they see?
    
    A prescription precedes shipping and the clinician is not described. The plan names do the work instead, and they describe a clinical position rather than a billing term, which is unusual.
    
    Almost every seller that varies price by term publishes the ladder; almost none that varies by dose does. MANÜ publishes the dose split directly, so a reader can see what escalating costs before they escalate. The distinction between starting and staying on lower doses is also stated, which acknowledges that some people do not move up.
    
2.  ## What happens when the dose goes up?
    
    This is the field MANÜ answers. Moving from the Starter Plan to the Full Dose Plan costs $100 a month on semaglutide and $100 on tirzepatide. A reader who expects to reach a full dose should price the second figure, not the first.
    
3.  ## What the price includes
    
    Six months on the Starter Plan is $1,194 for semaglutide and $1,782 for tirzepatide. On the Full Dose Plan the same spans are $1,794 and $2,382. The word starting attaches to both entry figures, so the Starter Plan has a floor of its own.
    
4.  ## What it claims, and what it cites
    
    Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
    

## Where it holds up, and where it does not

-   Strength: Both dose plans priced, not just the entry one
-   Strength: The split is by dose, stated plainly
-   Strength: Staying on a low dose is acknowledged
-   Limitation: Full dose costs $100 more a month
-   Limitation: Both entry figures say starting at
-   Limitation: No milligram thresholds published
-   Limitation: No state coverage list is recorded

## What the evidence says about this kind of treatment

The assessment above is about MANÜ Telehealth. These are about the drugs it sells, and they are traced to the primary literature.

-   [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1)
-   [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1)
-   [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain)

Right for

A reader who wants the cost of a full dose stated before starting a low one.

Wrong for

A reader budgeting a year from the Starter Plan figure.

## The evidence behind what MANÜ Telehealth prescribes

These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.

-   [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review)
    
    A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
    
-   [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better)
    
    In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
    

## How MANÜ Telehealth compares

| Seller | Who it suits | Go |
| --- | --- | --- |
| MaxLife | Readers who will ask what the starter kit covers and what follows it |  |
| LeanDose | Readers who will get the month-two rate in writing before the first charge |  |
| LevelUp Rx | Readers who want the billed total before committing to a term |  |

[Compare all providers side by side →](https://thisglp.com/best)

More GLP-1 telehealth sellers reviews: [Vea Health](https://thisglp.com/reviews/vea-health) [Vela Rx](https://thisglp.com/reviews/vela-rx) [Verge](https://thisglp.com/reviews/verge) [Vida Health](https://thisglp.com/reviews/vida-health) [Virgo-Meds](https://thisglp.com/reviews/virgo-meds) [Virta Health](https://thisglp.com/reviews/virta-health)

Sponsored alternative

SkinnyRx

Readers choosing tirzepatide, the one line with a published standing rate

## Frequently asked

What does a full dose cost?

$299 a month for semaglutide and $397 for tirzepatide, against Starter Plan figures of $199 and $297.

Where is the line between the two plans?

MANÜ describes the Starter Plan as entry pricing for patients starting or staying on lower doses, without publishing a milligram threshold.

Is $199 a fixed rate?

It is a starting figure for the Starter Plan, so it is a floor within the lower tier rather than a settled rate.

Is MANÜ Telehealth expensive compared with other GLP-1 telehealth sellers?

MANÜ Telehealth publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts MANÜ Telehealth above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.

Or [compare every seller we cover](https://thisglp.com/best).

**Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).
